STAT

NOVEMBER 30, 2023

ASHEVILLE, N.C. — There was the beeping of monitors, the stiff sheets, the sterile smell of the hospital room. Mostly, there was pain. Sharp, relentless pain. Mike Messino was recovering from a successful surgery, but the nerve blocks had worn off. He spent two full hours waiting for a nurse to inject pain medication. When he’d worked in this hospital, he’d made sure patients didn’t wait longer than 15 minutes for that kind of care.

Hospitals 351

Hospitals 351

PharmaVoice

NOVEMBER 30, 2023

John Mulligan, founder of biotechs like Good Therapeutics and Bonum Therapeutics, discusses how biotechs can thrive when the market is against them.

277

277

STAT

NOVEMBER 30, 2023

The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” and “intentionally” misrepresenting the effectiveness of its Covid-19 vaccine and attempting to censor its critics. The pharmaceutical company violated a state law — the Texas Deceptive Trade Practices Act — by making unsupported claims that its shot was durable and capable of protecting against transmission, according to the 54-page lawsuit filed in a state court by Texas Att

Vaccines 312

Vaccines Pharmaceutical Companies Pharmaceutical Companies 312

Pharma Times

NOVEMBER 30, 2023

The new hub will unite researchers worldwide to exchange ideas and knowledge - News - PharmaTimes

132

132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 30, 2023

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology. Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian ca

Chemotherapy 294

Chemotherapy 294

Safe Biologics

NOVEMBER 30, 2023

In November, ASBM released two fact sheets on interchangeable biosimilars. Download them here: Physician Perspectives on Interchangeable Biosimilars Interchangeable Biosimilars: Comparing Europe and the U.S.

Biosimilars 130

Biosimilars 130

Pharma Times

NOVEMBER 30, 2023

The new method successfully performs sterility assessments within 24 hours - News - PharmaTimes

123

123

STAT

NOVEMBER 30, 2023

Many commonly suggested ways to addressing climate change present few ethical challenges: Cut fossil fuels. Eat less meat. Don’t buy fast fashion. But what happens when products that contribute to climate change also save lives — millions of them? A new report , published on Nov. 28 by the global health initiative Unitaid, looks into this issue, quantifying the environmental impact of 10 essential public health items.

272

272

pharmaphorum

NOVEMBER 30, 2023

AbbVie has moved to shore up its pipeline following the loss of patent protection for its top-selling drug with a $10.1 billion deal to buy ImmunoGen and its marketed ovarian cancer drug.

115

115

STAT

NOVEMBER 30, 2023

Worried about your health? You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s. Even before the Covid pandemic, a 2018 paper reported that new genetic tests, many of them for increasingly rare conditions, were being released at the rate of 10 a day.

Labelling 260

Labelling 260

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

NOVEMBER 30, 2023

FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year. Bumpus is heading for the number two position at the FDA – second only to Commissioner Robert Califf who announced the appointment on X (formerly Twitter) – just over a year after she joined the agency.

113

113

STAT

NOVEMBER 30, 2023

Rise and shine, everyone, another busy day is on the way. We can tell because the official mascots are racing madly about the Pharmalot grounds chasing creatures, and the parade of vehicles outside our window is picking up rapidly. As for us, we are dutifully firing up the coffee kettle to brew another cup of needed stimulation. Our choice today is blueberry cobbler.

Compounding 208

Compounding Compounding Pharmacies Chemotherapy 208

European Pharmaceutical Review

NOVEMBER 30, 2023

Biocon Biologics Ltd has successfully completed integration of Viatris’ biosimilar business in 31 European countries. Following the acquisition of substantially all global biosimilar business of Viatris in November 2022, and the related integration of over 70 emerging market countries in July 2023 and North America in September 2023, now that Viatris’ biosimilars operations have fully transitioned to Biocon Biologics Ltd in Europe, the company declared that this “represents another significant m

Biosimilars 111

Biosimilars 111

STAT

NOVEMBER 30, 2023

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it delivered in your inbox every Tuesday and Thursday.

Hospitals 203

Hospitals 203

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 30, 2023

UK Biobank releases largest-ever genome sequencing dataset Phil.

108

108

STAT

NOVEMBER 30, 2023

Are ADCs having a moment? Is CAR-T safe? And who’s to blame for failed trials? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss why AbbVie is spending $10 billion on a cancer-focused company that spent four decades on the path to its first FDA approval, a deal with implications for biotech in 2023 and for a burgeoning area in oncology.

187

187

Express Pharma

NOVEMBER 30, 2023

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Ivabradine Tablets, 5 mg and 7.5 mg (USRLD: Corlanor Tablets, 5 mg and 7.5 mg). Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction.

105

105

STAT

NOVEMBER 30, 2023

Radiology has long led the way in the application of artificial intelligence in medicine. More than three-quarters of AI and machine learning devices authorized by the Food and Drug Administration work with medical images — and that dominance was evident at this year’s meeting of the Radiological Society of North America, where AI vendors gathered to tout their latest offerings.

180

180

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

NOVEMBER 30, 2023

As more cell and gene therapies get approved to treat common conditions, scaling them up will be a challenge.

105

105

STAT

NOVEMBER 30, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a rebound for biotech stocks, the potential of Wegovy, and a major change at the FDA.

Drug Pricing 118

Drug Pricing Drug Development 118

European Pharmaceutical Review

NOVEMBER 30, 2023

In a paper published in Microbiology Spectrum , researchers from Singapore have described a novel microbial contamination-detection method for T-cell cultures that can be achieved within 24 hours, therefore supporting cell therapy manufacturing. This is compared to traditional methods which take between seven to 14 days. Technology such as third-generation nanopore long-read sequencing and DNA extraction, alongside machine learning algorithms, computational analysis and optimisation, were utili

105

105

Express Pharma

NOVEMBER 30, 2023

ACG’s latest capsule filling machine is a customer-centric concept design, developed in ACG’s German R&D facility, that emphasises simplicity, safety, and efficiency ACG has unveiled its next generation capsule filling machine at CPHI and PMEC India 2023. ACG’s latest capsule filling machine is a customer-centric concept design, developed in ACG’s German R&D facility, that emphasises simplicity, safety, and efficiency.

Packaging 104

Packaging 104

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 30, 2023

Astellas builds case for menopause drug fezolinetant Phil.

103

103

Pharmaceutical Technology

NOVEMBER 30, 2023

The move is a strategic response amid challenges faced by the non-viral gene therapy sector, with several startups closing this year.

98

98

PharmExec

NOVEMBER 30, 2023

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but serious and potentially fatal reaction linked to use of antiseizure medications.

98

98

European Pharmaceutical Review

NOVEMBER 30, 2023

o find out about the current trends in cell and gene therapy manufacturing, EPR spoke to Cell and Gene Therapy Catapult (CGT Catapult)’s Chief Manufacturing Officer, Stephen Ward, and Chief Business Officer, Jeanette Evans. They highlighted key data from the organisations recently published good manufacturing practice (GMP) Manufacturing Survey and Skills Demand reports, which focus particularly on the UK’s landscape.

Medical Schools 97

Medical Schools 97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmExec

NOVEMBER 30, 2023

The use of real-world evidence can prevent pharma companies from performing studies based on flawed data.

97

97

PharmaTech

NOVEMBER 30, 2023

Exagamglogene autotemcel seen as synechdoche.

96

96

pharmaphorum

NOVEMBER 30, 2023

PCR in pharma packaging: A sustainable solution for tomorrow? Mike.

Packaging 94

Packaging 94

The Guardian - Pharmaceutical Industry

NOVEMBER 30, 2023

Asthma sufferers among those rationing drugs amid shortages and high prices after the pharmaceutical company ceased business in Nigeria this year Salamat Olashile takes a tablet from a white-and-green sachet. Five minutes later, her breathing is still laboured. “It will soon come down,” she says. She used to have an inhaler, which would have eased her asthma attack faster, but prices have increased dramatically since GlaxoSmithKline (GSK) “exited” the country.

Pharmaceutical Companies 88

Pharmaceutical Companies Pharmaceutical Companies 88

pharmaphorum

NOVEMBER 30, 2023

Could high HDL-cholesterol raise dementia risk? Phil.

88

88